| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.22 | 0.006 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.007 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.01 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |